X 4 Pharmaceuticals Inc has split its stock 2 times since its initial public offering (IPO). The first stock split occurred on March 14, 2019 with the ratio of 1-for-6, meaning that for 6 shares of XFOR owned pre-split, shareholders then owned 1 share. The most recent stock split took place on April 28, 2025 on a 1-for-30 basis.
These actions have increased XFOR stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that a stock split only change the number of shares and the price per share with no impact on X 4 Pharmaceuticals Inc's total market capitalization.
For more detailed information of X 4 Pharmaceuticals Inc's stock splits, view the table below:
The answer will depend on the decisions of the company's managers and market volatility. X 4 Pharmaceuticals Inc has not made an official announcement regarding whether it will enact a stock split or reverse stock split, but it has a history of doing so when XFOR stock prices become too high or too low for retail investors. Therefore, the ultimate decisions will certainly be made by X 4 Pharmaceuticals Inc's board of directors. Typically, no action is taken until its price per share reaches a specific threshold.
